Bayer looks to new Eylea use in Japan; Hep C cases drop 16%; Stada says Ukraine business steady amid conflict;

@FiercePharma: As in...right now. The top 10 pharma companies by 2013 revenue report is live on the FP site. Report | Follow @FiercePharma

@TracyStaton: This year's version of FiercePharma's most popular special report: The top 10 pharma companies by 2013 revenue. More | Follow @TracyStaton

@EricPFierce: WSJ says Pfizer angling for OTC Lipitor. That will get generic drugmakers' notice. Story | Follow @EricPFierce

@CarlyHFierce: New report, now live: The top 10 pharma companies by 2013 revenue. Report | Follow @CarlyHFierce

> Bayer submitted its vision drug, VEGF Trap-Eye, for approval in patients with diabetic macular edema in Japan; it's sold elsewhere as Eylea. Release

> Germany's Stada says conflict in the Ukraine, its second-biggest market, hasn't affected its business in that country. Report

> Hepatitis C cases dropped 16% to 2.7 million over a decade, the Centers for Disease Control and Prevention, at a time when new treatments are edging onto the market. Report

> Many painkiller addicts visit multiple doctors to get their pills, suggesting physicians need to be more vigilant when recommending their use. Report

> Forest Laboratories ($FRX) said it submitted its application for FDA approval of a combination Alzheimer's disease pill comprising its Namenda drug (memantine) and donezepil, sold by Pfizer ($PFE) under the brand name Aricept. Release

Medical Device News

@FierceMedDev: Mindray, a giant Chinese medical device company, has just expanded an already impressive share repurchase program. More | Follow @FierceMedDev

@MarkHFierce: Google Glass is showing some promise as a medical diagnostic tool. Cool stuff, with pictures. Story | Follow @MarkHFierce

@MichaelGFierce: New manufacturing technique offers tailored delivery nanoparticles made of iron, silver and silicon. More from FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: Researchers created custom-fitting heart sacs that could help with treatment. Article | Follow @EmilyWFierce

> Invuity brings a new $36M in growth equity to the surgical tools market. News

> Germany's Biotronik wins a CE mark for a super-tiny, MRI-safe CRT lead. Story

> Oxford Immunotec reports narrowed loss, Asia growth in first earnings post-IPO. Report

Biotech News

@FierceBiotech: Theravance bets it can innovate without GlaxoSmithKline as spinoff nears. Story | Follow @FierceBiotech

@JohnCFierce: The coming Zohydro addiction issue is a natural mainstream media piece--sets the FDA up for a big black eye with more to come. Story via CBS | Follow @JohnCFierce

@DamianFierce: On his farewell tour, Roche Chairman Franz Humer says Roche is poised for some dealmaking. News | Follow @DamianFierce

@EmilyMFierce: BioCryst compound prevents Marburg virus in monkeys. Article | Follow @EmilyMFierce

> Oxygen Bio shares soar after FDA lifts hold on brain injury drug. More

> Biotech parties on with billions more raised for R&D work. Story

Biotech Research News

> HIV immune discovery could lay the groundwork for a vaccine. Story

> Experimental supplement extends lifespan, stops metabolic disease in mice. Article

> BioCryst compound prevents Marburg virus in monkeys. News

> New anti-inflammatory molecule could provide a model for new drug design. Article

> Brain cell communication plays role in regulating Alzheimer's protein. Story

> NIH makes new database on age-related diseases available to researchers. Brief

Pharma Manufacturing News

> Regeneron preparing for a plant expansion and a fill-finish facility in Ireland. Story

> Jubilant says the FDA has cleared its Canada plant. News

> Fresenius to build new plant in Australia. Story

> Lilly invests in its Brazilian packaging plant. Article

> Drug purchasing group wants drugmakers to work with GPOs on shortages. Story

> Pharma packaging market is forecast to hit $90 billion in 2017. Brief

And Finally... Scientists have been testing LSD to ease anxiety in the terminally ill. Report